Recruiting soon

Probiotics and Activated Charcoal for Uremic Pruritus in Chronic Kidney Disease

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Probiotic Blend Capsule

+ Activated Charcoal

Drug
Who is being recruted

Urogenital Diseases+15

+ Anthrax

+ Bacterial Infections and Mycoses

From 18 to 75 Years
+5 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Phase 2
Interventional
Study Start: September 2024
See protocol details

Summary

Principal SponsorAin Shams University
Study ContactAliaa Mohamed Ashraf
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: September 1, 2024

Actual date on which the first participant was enrolled.

Chronic kidney disease-associated pruritus is an uncomfortable condition that leads to a persistent need to scratch, significantly affecting the quality of life for those with chronic kidney disease. This study aims to explore whether probiotics or activated charcoal can help manage this skin itching problem. By investigating ways to reduce the levels of certain toxins in the body that contribute to this itchiness, this study hopes to find more effective treatments. Probiotics might help by improving the balance of good bacteria in the body, while activated charcoal may work by absorbing these toxins before they get into the bloodstream. Participants in this study will receive either probiotics or activated charcoal. Probiotics are taken orally and work by enhancing the gut's bacterial environment, potentially leading to improvements in skin conditions. Activated charcoal, also taken orally, acts by capturing toxins within the digestive system, thus reducing their levels in the blood. The effectiveness of these treatments will be evaluated based on how much they can reduce the sensation of itching and improve the participants' overall quality of life. Both treatments are being tested for their ability to offer relief without causing serious side effects.

Official TitleThe Effect of Probiotics Versus Activated Charcoal in the Management of Chronic Kidney Disease Patients Suffering From Uremic Pruritus.
NCT06579066
Principal SponsorAin Shams University
Study ContactAliaa Mohamed Ashraf
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

123 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 75 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Urogenital DiseasesAnthraxBacterial Infections and MycosesBacterial InfectionsChronic DiseaseFemale Urogenital Diseases and Pregnancy ComplicationsInfectionsKidney DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsUrologic DiseasesBacillaceae InfectionsGram-Positive Bacterial InfectionsDisease AttributesRenal Insufficiency, ChronicRenal InsufficiencyFemale Urogenital DiseasesMale Urogenital Diseases

Criteria

1 inclusion criteria required to participate
Adult Patients with uremic pruritus aged from 18 years and older will be enrolled in the study.

4 exclusion criteria prevent from participating
Patient undergoing dialysis.

Patients with psoriasis, atopic dermatitis or any other condition that can justify pruritus.

Patients with known allergy to Activated charcoal or probiotics supplements.

Patients who are non-compliant.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Patients will administer Linex ® capsule orally along with the standard care of therapy for duration of 4 weeks. Dose: Capsule once daily

Group II

Experimental
Patients will administer Charclone® 1000mg tab orally along with the standard care of therapy for duration of 4 weeks. Dose: Tablet three times daily.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has no location dataSave this study to your profile to know when the location data is available.
Recruiting soonNo study centers